. 13 C NMR Spectral Data for [4] [5] [6] [7] [10] [11] [12] [13] δ, ppm) 6. Table S2 . 13 C NMR Spectral Data for 15, [22] [23] [24] [25] [26] [27] δ, ppm) 7. Table S3 . 13 C NMR Spectral Data for [28] [29] [30] [31] [32] [33] [34] [35] δ, ppm) 8. Table S4 . 13 C NMR Spectral Data for 36, [38] [39] [40] 42, 44, 45 (CDCl3, δ, ppm) 9. S2. X-ray crystal structure analysis for compounds 5, 24, 27, and 36 10. Table S5 . XRD data for compounds 5, 24, 27 and 36 11. Table S6 . Parameters of the short inter-molecular and the selected intra-molecular contacts for 24, 27, and 36 12. S3 . C-NMR spectra for compounds 4-7, 10-13, 15, 22-36, 38-40 42, 44, and 45 the tricyclic diterpenoid core atoms numeration system given in structure 2 was used. The following abbreviations heve been used to denote the multiplicities: s (singlet), d (doublet), t (triplet), q (quartetr), m (multiplet). IR absorption spectra were obtained with a Bruker Vector-22 spectrometer, and values are reported in cm -1
. UV spectra were obtained with an HP 8453 UV-Vis spectrometer (Hewlett-Packard, Waldbronn, Germany) in EtOH. HRMS spectra were recorded with a DFS spectrometer (Thermo Scientific, evaporator temperature 240-270 o C). The melting points were determined on a Stuart SMF-38 melting point apparatus (Bibby Scientific, Staffordshire, UK) and are uncorrected. Specific rotation [α]D was measured at room (20-23°C) temperature in CHCl3 on a PolAAr 3005 polarimeter. XRD data for compounds 5, 24, 27 were obtained on a Bruker Kappa Apex II CCD diffractometer using φ, ω scans of narrow (0.5°) frames with Mo Kα radiation (λ = 0.71073 Å ) and a graphite monochromator. The structure was solved by direct methods and refined by full-matrix least-squares method against all F2 in anisotropic approximation using the SHELX-97 programs set. [24] The hydrogen atoms positions were calculated with the riding model. Absorption corrections were applied using the empirical multiscan method with the SADABS program. [25] The analytical and spectroscopic investigations were carried out at the Collective Use Center for Chemical Services of the Siberian Branch of the Russian Academy of Sciences.
The reaction progress and the purity of the obtained compounds were monitored by TLC on Silufol UV-254 plates (Kavalier, Czech Republic, CHCl3-EtOH, 100:1; detection under UV light or by spraying the plates with 10% water solution of H2SO4 followed by heating at 100 o C). Column chromatography was performed by using silica gel 60 (0.063-0.200 mm, Merck KGaA, Darmstadt, Germany).
All solvents were freshly distilled under argon prior to being used. Anilines 3,8,9,16-21,37, benzenesulfonamide (41) and tert-butyl carbamate (43) were commercially obtained from Aldrich and Alpha Aesar. Methyl 14α-hydroxy-15,16-dihydroisopimarate (2) was prepared according to the literature procedure.
[9]
(1R,4aR,4bR,7S,9R,10aR)-Methyl 9-((2-chloro-4-nitrophenyl)amino)-7-ethyl-1,4a,7-trimethyl-1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydrophenan-threne-1-carboxylate (23). Compound 2 (500 mg, 1.5 mmol) was dissolved in CH3CN (10 mL) and 2-chloro-4-nitroaniline (17) (520 mg, 3.0 mmol), AuCl3 (9 mg, 0.03 mmol), and AgOTf (23 mg, 0.09 mmol) were added in succession under stirring. The mixture was stirred for 24 h at room temperature, the solvent was removed under reduced pressure, and the residue was subjected to column chromatography on silica gel to afford diene 6 (66 mg, 14%) and compound 23 as a yellow oil (381 mg, 52%).
(1R,4aR,4bR,7S,9R,10aR)-Methyl 7-ethyl-9-((4-methoxy-2-nitrophenyl)-amino)-1,4a,7-trimethyl-1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydrophenan-threne-1-carboxylate (24). Compound 2 (500 mg, 1.5 mmol) was dissolved in CH3CN (10 mL) and 4-methoxy-2-nitroaniline (18) (504 mg, 3.0 mmol), AuCl3 (9 mg, 0.03 mmol) and AgOTf (23 mg, 0.09 mmol) were added in succession under stirring. The mixture was stirred for 24 h at room temperature, the solvent was removed under reduced pressure, and the residue was subjected to chromatography on silica gel to afford dienes 5 (24 mg, 5%), 6 (14 mg, 3%), and compound 24 as a red powder (589 mg, 81%).
(1R,4aR,4bR,7S,9R,10aR)-Methyl 7-ethyl-1,4a,7-trimethyl-9-((3-(trifluoromethyl)phenyl)amino)-1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydro-phenanthrene-1-carboxylate (25). To a stirred solution of compound 2 (500 mg, 1.5 mmol) and 3-(trifluoromethyl)aniline (18) (483 mg, 3.0 mmol) in CH3NO2 (5 mL) AuCl3 (9 mg, 0.03 mmol), and AgOTf (23 mg, 0.09 mmol) were added. The mixture was stirred for 24 h at room temperature, the solvent was removed under reduced pressure, and the residue was subjected to column chromatography on silica gel to afford compounds 5 (9 mg, 2%), 6 (9 mg, 2%), 25 as a colorless oil (343 mg, 48%), 33 as a pale yellow oil (93 mg, 13%), and 32 as a pale yellow oil (143 mg, 20%).
(1R,4aR,4bR,7S,9R,10aR)-Methyl 7-ethyl-1,4a,7-trimethyl-9-((4-(trifluoromethyl)phenyl)-amino)-1,2,3,4,4a,4b,5,6,7,9,10,10a-dodeca-hydrophenanthrene-1-carboxylate (26). Compound 2 (500 mg, 1.5 mmol) was dissolved in CH3CN (10 mL) and 4-(trifluoromethyl)aniline 20 (483 mg, 3.0 mmol), AuCl3 (9 mg, 0.03 mmol), and AgOTf (23 mg, 0.09 mmol) were added in succession under stirring. The mixture was stirred for 24 h at room temperature, the solvent was removed under reduced pressure, and the residue was subjected to column chromatography on silica gel to afford compounds 26 as a pale yellow oil (501 mg, 70%), 35 (100 mg, 14%), 34 as a pale yellow oil (100 mg, 14%), and 14 (30 mg, 6%).
(1R,4aR,4bR,7S,9R,10aR)-Methyl 9-((4-acetylphenyl)amino)-7-ethyl-1,4a
,7-trimethyl-1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydrophenanthrene-1-carboxylate (27). Compound 2 (500 mg, 1.5 mmol) was dissolved in CH3NO2 (5 mL) and 1-(4-aminophenyl)ethanone 21 (400 mg, 3.0 mmol), AuCl3 (9 mg, 0.03 mmol), and AgOTf (23 mg, 0.09 mmol) were added in succession under stirring. The mixture was stirred at 25 °C for 24 h. The solvent was distilled off under reduced pressure, and the residue was subjected to column chromatography on silica gel to afford compounds 27 as an orange oil (454 mg, 67%) and 36 (76 mg, 11%).
(1R,4aR,4bR,7S,9S,10aR)-Methyl 7-ethyl-1,4a,7-trimethyl-9-(methyl(4-nitrophenyl)-amino)-1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydrophenan-threne-1-carboxylate (38). Compound 2 (500 mg, 1.5 mmol) was dissolved in CH3CN (10 mL) and N-methyl-4-nitroaniline (37) (456 mg, 3.00 mmol), AuCl3 (9 mg, 0.03 mmol), and AgOTf (23 mg, 0.09 mmol) were added in succession under stirring. The mixture was stirred for 24 h at room temperature, the solvent was removed under reduced pressure, and the residue was subjected to column chromatography to afford compounds 5 (149 mg, 31%), 6 (14 mg, 3%), 38 as an yellow oil (126 mg, 18%), and 39 as a colorless oil (148 mg, 15%).
(1R,4aR,4bR,7S,9S,10aR)-Methyl 7-ethyl-1,4a,7-trimethyl-9-((4-nitrophenyl)amino)-1,2,3,4, 4a,4b,5,6,7,9,10,10a-dodecahydrophenanthrene-1-carboxylate (40). Dimer 39 (500 mg, 0.77 mmol) was dissolved in CH3NO2 (5 mL) and 4-nitroaniline (8) (212 mg, 1.54 mmol), AuCl3 (5 mg, 0.02 mmol), and AgOTf (11 mg, 0.05 mmol) were added in succession under stirring. The mixture was stirred for 24 h at room temperature, the solvent was removed under reduced pressure, and the residue was subjected to column chromatography to afford compounds 5 (185 mg, 38%), 10 (160 mg, 23%), and 40 as an yellow oil (160 mg, 23%).
(1R,4aR,4bR,7S,9R,10aR)-Methyl 7-ethyl-1,4a,7-trimethyl-9-(phenyl-sulfonamido)-1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydrophenanthrene-1-carboxylate (42). Compound 2 (500 mg, 1.50 mmol) was dissolved in CH3CN (10 mL) and benzenesulfonamide (41) (472 mg, 3.00 mmol), AuCl3 (5 mg, 0.02 mmol), and AgOTf (11 mg, 0.05 mmol) were added in succession under stirring. The mixture was stirred for 24 h at room temperature, the solvent was removed under reduced pressure, and the residue was subjected to column chromatography on silica gel to afford compounds 5 (57 mg, 12%), 6 (28 mg, 6%), and 42 as a white solid (291 mg, 41%).
(1R,4aR,4bR,7S,9R,10aR)-Methyl 9-((tert-butoxycarbonyl)amino)-7-ethyl-1,4a,7-trimethyl-1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydrophenanthrene-1-carboxylate (44). Compound 2 (500 mg, 1.5 mmol) was dissolved in CH3NO2 (5 mL) and tert-butyl carbamate (43) (351 mg, 3.00 mmol), AuCl3 (9 mg, 0.03 mmol), and AgOTf (23 mg, 0.09 mmol) were added in succession under stirring. The mixture was stirred for 24 hat room temperature, the solvent was removed under reduced pressure, and the residue was subjected to column chromatography on silica gel to afford compound 44 as a colorless oil (422 mg, 65%).
(1R,4aR,4bR,7S,9R,10aR)-Methyl 9-amino-7-ethyl-1,4a,7-trimethyl-1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydrophenanthrene-1-carboxylate (45). Compound 44 (500 mg, 1.5 mmol) was dissolved in CH3OH (10 mL) and 1.5 mL of concentrated HCl was added under stirring at 20°C and the mixture was left to stand for 24 h at 20°C, then treatment by adding of 0.5 mL of triethylamine. The solvent was evaporated under reduced pressure. Water (5 mL) was added and extractions with CH2Cl2 (4 × 10 mL) was performed. The combined organic Layers were dried with magnesium sulfate, filtrated and concentrated in vacuo. The oily residue was purified by column chromatography on silica gel using petroleum ether-methanol (10 : 1) as an eluent, to afford compound 45 as a colorless oil (450 mg, 90%).
Treatment of 2 with AuCl3 in CH3CN.
A solution of compound 2 (500 mg, 1.5 mmol) in CH3CN (10 mL) was treated by AuCl3 (9 mg, 0.03 mmol). After stirring of the mixture for 24 h at ambient temperature, the solvent was removed under reduced pressure, and the residue was subjected to column chromatography on silica gel to afford compounds 5 (50 mg, 8%), 39 (148 mg, 15%), 14 (140 mg, 28%), and 2 (180 mg).
Treatment of 2 with AuCl3-AgOTf in CH3NO2. Compound 2 (500 mg, 1.50 mmol) was dissolved in CH3NO2 (5 mL) and AuCl3 (9 mg, 0.03 mmol) and AgOTf (23 mg, 0.09 mmol) were added under stirring. The mixture was stirred for 24 h at room temperature, the solvent was removed under reduced pressure, and the residue was subjected to column chromatography to afford dienes 5 (144 mg, 23%), 6 (325 mg, 69%) and starting compound 2 (11 mg).
Reaction of methyl 7α-hydroxy-15,16-dihydrosandaracopimarate (14) with 3-nitroaniline (9). Compound 14 (500 mg, 1.50 mmol) was dissolved in CH3NO2 (5 mL) and 3-nitroaniline (9) (410 mg, 3.00 mmol), AuCl3 (9 mg, 0.03 mmol), and AgOTf (23 mg, 0.09 mmol) were added in succession under stirring. The mixture was stirred for 24 h at room temperature, the solvent was removed under reduced pressure, and the residue was subjected to column chromatography to afford compounds 12 (347 mg, 51%), 13 (46 mg, 7%), 15 (105 mg, 15%), and 14 (100 mg, 13%).
X-ray crystal structure analysis for compounds 5, 24, 27, and 36: The compounds 24, 27 crystallizes in the orthorhombic space groups P212121, while 5, 36 crystallizes in the monoclinic P21 group. The crystallographic data are listed in Table S5 . Molecular structure of compounds 6, 24, 27, 36 is illustrated in Fig. 2 Table S1 . IR (neat): ν˜ =746, 1035, 1145, 1190, 1244, 1259, 1278, 1338, 1352, 1419, 1444, 1460, 1506, 1571, 1616, 1724, 2848, 2868, 2925, 2949 cm -1 . Table S1 . IR (neat): ν˜ =1112, 1149, 1188, 1244, 1384, 1434, 1460, 1616, 1728, 2850, 2866, 2935, 3012 cm -1 . Table S1 (Supp. Info). IR (neat): ν˜ =758, 1099, 1143, 1172, 1188, 1252, 1340, 1387, 1407, 1460, 1517, 1562, 1591, 1633, 1724, 2850, 2869, 2945, 3489, 3365, 3489 cm -1 . UV (EtOH) λmax nm (lgε): 236 Table S1 . IR (neat): ν˜ = 833, 1065 IR (neat): ν˜ = 833, , 1084 IR (neat): ν˜ = 833, , 1111 IR (neat): ν˜ = 833, , 1188 IR (neat): ν˜ = 833, , 1242 IR (neat): ν˜ = 833, , 1275 IR (neat): ν˜ = 833, , 1320 IR (neat): ν˜ = 833, , 1474 IR (neat): ν˜ = 833, , 1504 IR (neat): ν˜ = 833, , 1526 IR (neat): ν˜ = 833, , 1599 IR (neat): ν˜ = 833, , 1726 IR (neat): ν˜ = 833, , 2853 IR (neat): ν˜ = 833, , 2945 . Hz, 2 Н, Н-2',6'), 8.03 (d, J = 8.6 Hz, 2 Н, Н-3',5').
13
C NMR (151 MHz, CDCl3): see Table S1 . IR (neat): ν˜ = 754, 833, 1065, 1111, 1146, 1188, 1246, 1267, 1308, 1435, 1474, 1503, 1531, 1599, 1711, 1722, 2855, 2870, 2928, 3379 cm -1 . Table S1 . IR (neat): ν = 734, 758, 825, 1060, 1080, 1095, 1122, 1132, 1145, 1190, 1215, 1247, 1348, 1384, 1433, 1446, 1460, 1485, 1529, 1581, 1622, 1724, 2852, 2868, 2931, 2947, 3402 cm -1 . UV (EtOH) λmax nm ( 6.78 (dd, J = 8.1, 2.1 Hz, 1 Н, Н-6'), 7.21 (t, J = 8.1 Hz, 1 Н, Н-5'), 7.29 (t, J = 2.1 Hz, 1 Н, Н-2'), 7.44 (dd, J = 8.1, 2.1 Hz, 1 Н, Н-4').
C NMR (151 MHz, CDCl3): see Table   S1 . IR (neat): ν˜ = 723, 741, 822, 1047, 1060, 1099, 1132, 1146, 1184, 1244, 1280, 1350, 1385, 1460, 1531, 1539, 1620, 1726, 2853, 2866, 2928, 2949 , 3399 cm Table S2 . IR (neat): ν˜ = 671, 735, 758, 826, 1103, 1121, 1146, 1190, 1215, 1250, 1348, 1385, 1433, 1460, 1477, 1528, 1582, 1622, 1713, 2855, 2870, 2878, 2930, 2949 , 3408 cm .48 (dt, J = 7.5, 1.8 Hz, 1 Н, Н-4'), 6.67 (dd, J =7.5, 1.8 Hz, 1 Н, Н-6'), 7.09 (dt, J =7.5, 1.6 Hz, 1 Н, Н-5'), 7.38 (dd, J =7.5, 1.6 Hz, 1 Н, Н-3').
C NMR (101 MHz, CDCl3): see Table S2 . IR (neat): ν˜ = 740, 1018 IR (neat): ν˜ = 740, , 1064 IR (neat): ν˜ = 740, , 1120 IR (neat): ν˜ = 740, , 1145 IR (neat): ν˜ = 740, , 1157 IR (neat): ν˜ = 740, , 1190 IR (neat): ν˜ = 740, , 1244 IR (neat): ν˜ = 740, , 1282 IR (neat): ν˜ = 740, , 1315 IR (neat): ν˜ = 740, , 1384 IR (neat): ν˜ = 740, , 1431 IR (neat): ν˜ = 740, , 1446 IR (neat): ν˜ = 740, , 1460 IR (neat): ν˜ = 740, , 1508 IR (neat): ν˜ = 740, , 1595 IR (neat): ν˜ = 740, , 1616 IR (neat): ν˜ = 740, , 1726 IR (neat): ν˜ = 740, , 2850 IR (neat): ν˜ = 740, , 2868 IR (neat): ν˜ = 740, , 2947 . UV (EtOH) λmax nm ( .57 (t, J = 7.8 Hz, 1 Н, Н-5'), 7.06 (dd, J = 7.8, 1.6 Hz, 1 Н, Н-6'), 7.24 (dd, J = 7.8, 1.6 Hz, 1 Н, Н-4').
C NMR (101
MHz, CDCl3): see Table S3 . IR (neat): ν˜ = 754, 1150, 1169, 1192, 1261, 1450, 1462, 1585, 1612, 1720, 2849, 2868, 2936, 2963, 3410, 3493 cm -1 . Table S3 . IR (neat): ν˜ = 756, 816, 1142, 1163, 1173, 1190, 1250, 1308, 1385, 1435, 1460, 1503, 1620, 1722, 2851, 2870, 2945 1.6 Hz, 1 Н, Н-5'), 7.38 (dd, J =8.1, 1.6 Hz, 1 Н, Н-3').
13
C NMR (101 MHz, CDCl3): see Table S3 . IR (neat): ν˜ = 738, 1016, 1062, 1105, 1120, 1145, 1188, 1244, 1280, 1321, 1384, 1431, 1462, 1510, 1595, 1695, 1726, 2850, 2868, 2925, 3417 cm -1 . 31 31 1250, 1308, 1385, 1435, 1460, 1503, 1620, 1722, 2851, 2870, 2945, 3373 cm -1 . Table S2 . IR (neat): ν˜ = 746, 894, 1062, 1122, 1139, 1245, 1282, 1325, 1448, 1458, 1500, 1527, 1589, 1720, 2852, 2868 Table S2 . IR (neat): ν˜ = 759, 931, 1041, 1049, 1062, 1141, 1190, 1240, 1284, 1344, 1411, 1444, 1460, 1517, 1571, 1726, 2850, 2868, 2949 , 3352 cm Table S2 . IR (neat): ν˜ = 698, 758, 781, 860, 871, 993, 1066, 1122, 1163, 1244, 1346, 1438, 1479, 1492, 1614, 1716, 2852, 2870, 2949, 3404 cm -1 . Table S3 . IR (neat): ν˜ = 698, 758, 783, 993, 1066, 1122, 1163, 1247, 1280, 1319, 1344, 1384, 1435, 1444, 1460, 1481, 1492, 1519, 1614, 1714, 1724, 2854, 2871, 2929 , 3404 cm Table S3 (Supp. Info). IR (neat): ν˜ = 698, 756, 783, 858, 871, 993, 1068, 1122, 1163, 1244, 1344, 1444, 1517, 1614, 1718, 2852, 2870, 2933 , 3398 cm Table S2 . IR (neat): ν˜ = 758, 823, 1060, 1082, 1110, 1159, 1186, 1242, 1251, 1325, 1365, 1435, 1446, 1460, 1531, 1616, 1716, 2852, 2870, 2947 Table S3 . Hz, 2 Н, Н-2',6'), 7.33 (d, J = 8.6 Hz 2 Н, Н-3',5').
C NMR (101 MHz, CDCl3): see Table S3 . IR (neat): ν˜ = 642, 657, 829, 1064, 1106, 1159, 1186, 1241, 1261, 1321, 1365, 1434, 1450, 1461, 1535, 1616, 1712, 2850, 2929, 2946, 3398 , 3415 cm Table S2 . IR (neat): ν˜ = 756, 825, 954, 1064, 1078, 1124, 1147, 1180, 1278, 1307, 1357, 1384, 1433, 1446, 1460, 1485, 1525, 1573, 1597, 1597, 1658, 1724, 2852, 2868, 2945 Table S4 . IR (neat): ν˜ = 592, 829, 1076, 1103, 1122, 1145, 1180, 1245, 1280, 1309, 1359, 1384, 1433, 1460, 1529, 1573, 1595, 1651, 1724, 2870, 2929 Table S4 . IR (neat): ν˜ = 754, 786, 827, 1109, 1149, 1197, 1211, 1244, 1317, 1386, 1460, 1492, 1512, 1595, 1683, 1726, 2852, 2871 Table S4 . IR (neat): ν˜ = 1037, 1060, 1082, 1122, 1143, 1186, 1245, 1384, 1433, 1460, 1597, 1728, 2850, see Table S4 . Table S4 . IR (neat): ν˜ = 530, 555, 582, 646, 691, 718, 972, 1040, 1061, 1094, 1123, 1163, 1192, 1244, 1294, 1327, 1341, 1387, 1416, 1447, 1460, 1720, 2864, 2928, 2947, 3306 , 3421 cm Table S4 . IR (neat): ν˜ = 1026, 1047, 1172, 1244, 1365, 1388, 1462, 1489, 1720, 2852, 2870, 2949, 3442 cm Table S4 . IR (neat): ν˜ = 1061, 1105, 1115, 1130, 1150, 1177, 1190, 1244, 1385, 1460, 1726, 2853, 2868, 2928, 2945 cm -1 . UV (EtOH) λmax nm ( Table S1 .
C NMR Spectral data for compounds 4-7, 10-13 (CDCl3, δ, ppm). The compounds 24, 27 crystallizes in the orthorhombic space groups P212121, while 5, 36 crystallizes in the monoclinic P21 group. The crystallographic data are listed in Table S5 . Molecular structure of compounds 6, 24, 27, 36 is illustrated in Fig. 2 Table S6 . Parameters of the short inter-molecular and the selected intra-molecular contacts.
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